Market Overview:
The global salivary gland infection market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of salivary gland infections, rising awareness about salivary gland infections, and technological advancements in the diagnosis and treatment of salivary gland infections. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global salivary gland infection market can be segmented into diagnostic and treatment segments. The diagnostic segment is further sub-segmented into imaging techniques (ultrasound scan, computed tomography scan) and laboratory tests (blood test, saliva test). The treatment segment is further sub-segmented into surgical procedures (sialadenectomy) and nonsurgical procedures (laser therapy). Based on application, the global salivary gland infection market can be divided into hospital care sector, clinic care sector, household care sector, and other sectors.
Product Definition:
A salivary gland infection is a condition that occurs when the saliva-producing glands become infected. The most common type of salivary gland infection is a bacterial one, but other types, such as viral or fungal infections, can also occur. Saliva helps to moisten and lubricate the mouth, and it also contains enzymes that help to break down food. The importance of saliva production cannot be overstated; without it, eating would be very difficult. Saliva also plays an important role in keeping the teeth healthy by helping to neutralize acids produced by bacteria in plaque and reducing the risk of tooth decay.
Diagnosis:
Introduction of new diagnostic techniques and devices for early diagnosis is a major driver expected to propel the growth of this market. For instance, introduction of molecular diagnostics such as PCR (polymerase chain reaction) which helps in accurate and faster diagnosis.
Treatment:
Treatment and it's usage in Salivary Gland Infection market is classified into Antibiotics, Local Anesthetics, Steroids and Immunosuppressants. Among these antibiotics are widely used for the treatment of dental infections as well as oral cancer.
Application Insights:
The other application segment includes research studies and was valued at USD 5.00 million in 2017. The increasing prevalence of infectious diseases, especially among the geriatric population is anticipated to drive the demand for salivary gland infection treatment over the forecast period. According to a study published by NCBI in 2018, it has been estimated that around 1% of adults aged 60 years and above were found to be suffering from some form of oral infections. Similarly, another study conducted by CDC reported that around 2% - 3% elderly people are affected with dental caries each year which requires professional cleaning or excavation procedures most of the time resulting in increased usage of salivary glands related products such as antiseptic mouthwash across clinics and hospitals worldwide driving its demand globally over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and increasing prevalence of diseases. The U.S., in particular, is one of the most affected countries owing to its large population and widespread distribution network for products & services pertaining to oral health care.
Asia Pacific is expected to register a lucrative growth over the forecast period due to improving economic conditions, growing awareness about oral hygiene among individuals as well as mass scale campaigns by various organizations promoting dental health & hygiene among people living in this region. Moreover, an increase in disposable income levels coupled with rising consumer preference for westernized dental treatments will further boost revenue generation prospects over the next eight years or so.
Growth Factors:
- Increasing incidence of salivary gland infection due to changing lifestyle and eating habits.
- Growing awareness about the symptoms and treatment options for salivary gland infection among people.
- Rising number of dental procedures that can lead to salivary gland infection.
- increasing prevalence of diabetes and other autoimmune diseases which are known to increase the risk of salivary gland infection .
Scope Of The Report
Report Attributes
Report Details
Report Title
Salivary Gland Infection Market Research Report
By Type
Diagnosis, Treatment
By Application
Hospital, Clinic, Household, Other
By Companies
AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services(US), Merck & Co.(US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Salivary Gland Infection Market Report Segments:
The global Salivary Gland Infection market is segmented on the basis of:
Types
Diagnosis, Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie Inc. (US)
- Allergan (Republic of Ireland)
- AstraZeneca (UK)
- FUJIFILM Holdings Corporation (Japan)
- General Electric Company (US)
- GlaxoSmithKline plc. (UK)
- Johnson & Johnson Services(US)
- Merck & Co.(US)
- Pfizer Inc.(US)
- Siemens Healthcare GmbH (Germany)
Highlights of The Salivary Gland Infection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnosis
- Treatment
- By Application:
- Hospital
- Clinic
- Household
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Salivary Gland Infection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Salivary gland infection is an infection of the salivary glands. The most common type of salivary gland infection is called strep throat.
Some of the major companies in the salivary gland infection market are AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services(US), Merck & Co.(US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany).
The salivary gland infection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Salivary Gland Infection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Salivary Gland Infection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Salivary Gland Infection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Salivary Gland Infection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Salivary Gland Infection Market Size & Forecast, 2018-2028
4.5.1 Salivary Gland Infection Market Size and Y-o-Y Growth
4.5.2 Salivary Gland Infection Market Absolute $ Opportunity
Chapter 5 Global Salivary Gland Infection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Salivary Gland Infection Market Size Forecast by Type
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Salivary Gland Infection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Salivary Gland Infection Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Household
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Salivary Gland Infection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Salivary Gland Infection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Salivary Gland Infection Analysis and Forecast
9.1 Introduction
9.2 North America Salivary Gland Infection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Salivary Gland Infection Market Size Forecast by Type
9.6.1 Diagnosis
9.6.2 Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Salivary Gland Infection Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Household
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Salivary Gland Infection Analysis and Forecast
10.1 Introduction
10.2 Europe Salivary Gland Infection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Salivary Gland Infection Market Size Forecast by Type
10.6.1 Diagnosis
10.6.2 Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Salivary Gland Infection Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Household
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Salivary Gland Infection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Salivary Gland Infection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Salivary Gland Infection Market Size Forecast by Type
11.6.1 Diagnosis
11.6.2 Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Salivary Gland Infection Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Household
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Salivary Gland Infection Analysis and Forecast
12.1 Introduction
12.2 Latin America Salivary Gland Infection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Salivary Gland Infection Market Size Forecast by Type
12.6.1 Diagnosis
12.6.2 Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Salivary Gland Infection Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Household
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Salivary Gland Infection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Salivary Gland Infection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Salivary Gland Infection Market Size Forecast by Type
13.6.1 Diagnosis
13.6.2 Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Salivary Gland Infection Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Household
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Salivary Gland Infection Market: Competitive Dashboard
14.2 Global Salivary Gland Infection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie Inc. (US)
14.3.2 Allergan (Republic of Ireland)
14.3.3 AstraZeneca (UK)
14.3.4 FUJIFILM Holdings Corporation (Japan)
14.3.5 General Electric Company (US)
14.3.6 GlaxoSmithKline plc. (UK)
14.3.7 Johnson & Johnson Services(US)
14.3.8 Merck & Co.(US)
14.3.9 Pfizer Inc.(US)
14.3.10 Siemens Healthcare GmbH (Germany)
